Lantheus Holdings, Inc. to Present at Upcoming Investor Conferences
Wednesday, August 24th 2016 at 8:05pm UTC NORTH BILLERICA, Mass.–(BUSINESS WIRE)– Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”),...
View ArticleSyros Pharmaceuticals to Present at BioCentury NewsMakers Conference
Friday, August 26th 2016 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Syros Pharmaceuticals (NASDAQ: SYRS) announced today that its Chief Executive Officer Nancy Simonian, M.D., will present a...
View ArticleSensorion to Present at the 18th Annual Rodman & Renshaw Global Investment...
Thursday, September 1st 2016 at 5:00pm UTC MONTPELLIER, France–(BUSINESS WIRE)– Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN), a biotech company specializing in the treatment of...
View ArticleGenSight Biologics receives Orphan Drug Designation and Advanced Therapy...
Thursday, September 1st 2016 at 5:30am UTC PARIS–(BUSINESS WIRE)– Regulatory News: GenSight Biologics (Euronext: SIGHT, FR0013183985, PEA-PME eligible), a biopharma company that discovers and develops...
View ArticleOvid Therapeutics Announces Participation in Two Upcoming Investor Conferences
Thursday, September 1st 2016 at 12:00pm UTC NEW YORK–(BUSINESS WIRE)– Ovid Therapeutics, Inc., a privately held biopharmaceutical company focused on developing therapies for orphan diseases of the...
View ArticleBellicum Pharmaceuticals to Present at the BioCentury 23rd Annual NewsMakers...
Thursday, September 1st 2016 at 11:00am UTC HOUSTON–(BUSINESS WIRE)– Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing...
View ArticleConcert Pharmaceuticals to Present at Upcoming Investor Conferences
Thursday, September 1st 2016 at 11:00am UTC LEXINGTON, Mass.–(BUSINESS WIRE)– Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will present a corporate overview at the following...
View ArticleTransgene Announces Participation at Upcoming Investor Events
Thursday, September 1st 2016 at 4:00pm UTC STRASBOURG, France–(BUSINESS WIRE)– Regulatory News: Transgene (Paris:TNG) today announced that management will participate in the upcoming investor events...
View ArticleCytori to Present in Investor Events in September 2016
Thursday, September 1st 2016 at 8:05pm UTC SAN DIEGO–(BUSINESS WIRE)– Cytori Therapeutics, Inc. (NASDAQ: CYTX), a late stage cell therapy company developing autologous cell therapies from adipose...
View ArticlePfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare...
Thursday, September 1st 2016 at 2:00pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Ian Read, Chairman and Chief...
View ArticleCerecor to Present at 23rd Annual NewsMakers in the Biotech Industry...
Thursday, September 1st 2016 at 1:10pm UTC BALTIMORE–(BUSINESS WIRE)– Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing treatments to make a difference in the lives of...
View ArticleCelmatix Names Mark Adams as Chief Information Officer
Thursday, September 1st 2016 at 1:00pm UTC Seasoned executive with deep experience in genomics, cloud computing, and data analytics to lead efforts to scale informatics systems NEW YORK–(BUSINESS...
View ArticlePremier Inc. to Present at September Investor Conferences
Friday, September 2nd 2016 at 12:36pm UTC CHARLOTTE, N.C.–(BUSINESS WIRE)– Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, will participate in three investor conferences during...
View ArticleLigand to Participate in Two Upcoming Investor Conferences
Friday, September 2nd 2016 at 1:00pm UTC SAN DIEGO–(BUSINESS WIRE)– Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that company executives are scheduled to participate in the following...
View ArticleBioTime to Present at Two Upcoming Investor Conferences
Tuesday, September 6th 2016 at 12:00pm UTC ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE MKT: BTX), a clinical stage biotechnology company with a focus on pluripotent stem cell technology,...
View ArticleNovaBay Pharmaceuticals to Present at the Rodman & Renshaw Global Investment...
Tuesday, September 6th 2016 at 10:50am UTC EMERYVILLE, Calif.–(BUSINESS WIRE)– NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its Avenova® lid...
View ArticlePoxel to Present at the 18th Annual Rodman & Renshaw Global Investment...
Tuesday, September 6th 2016 at 6:30am UTC LYON, France–(BUSINESS WIRE)– POXEL S.A. (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments...
View ArticleNeuroMetrix Announces Participation at the 18th Annual Rodman & Renshaw...
Tuesday, September 6th 2016 at 3:00pm UTC WALTHAM, Mass.–(BUSINESS WIRE)– NeuroMetrix, Inc. (NASDAQ:NURO) today announced it will be featured as a presenting company at the 18th Annual Rodman &...
View ArticleBristol-Myers Squibb to Announce Results for Third Quarter 2016 on October 27
Wednesday, September 7th 2016 at 3:17pm UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the third quarter of 2016 on Thursday, October 27, 2016. During...
View ArticleIronwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare...
Wednesday, September 7th 2016 at 3:40pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will participate in a fireside chat at the Morgan Stanley Global Healthcare...
View Article